The Early Events That Initiate β-Amyloid Aggregation in Alzheimer's Disease

被引:83
|
作者
Zhang, Xingyu [1 ]
Fu, Zhihui [1 ]
Meng, Lanxia [1 ]
He, Mingyang [1 ]
Zhang, Zhentao [1 ]
机构
[1] Wuhan Univ, Renmin Hosp, Dept Neurol, Wuhan, Hubei, Peoples R China
来源
FRONTIERS IN AGING NEUROSCIENCE | 2018年 / 10卷
基金
中国国家自然科学基金;
关键词
Alzheimer's disease; beta-amyloid; aggregation; age; diabetes; TRAUMATIC BRAIN-INJURY; APOLIPOPROTEIN APO E4; A-BETA; OXIDATIVE STRESS; HEAD-INJURY; DIABETES-MELLITUS; PRECURSOR PROTEIN; MOUSE MODEL; INFLAMMATORY S100A9; MICROGLIAL RESPONSE;
D O I
10.3389/fnagi.2018.00359
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Alzheimer's disease (AD) is characterized by the development of amyloid plaques and neurofibrillary tangles (NFTs) consisting of aggregated beta-amyloid (A beta) and tau, respectively. The amyloid hypothesis has been the predominant framework for research in AD for over two decades. According to this hypothesis, the accumulation of A beta in the brain is the primary factor initiating the pathogenesis of AD. However, it remains elusive what factors initiate A beta aggregation. Studies demonstrate that AD has multiple causes, including genetic and environmental factors. Furthermore, genetic factors, many age-related events and pathological conditions such as diabetes, traumatic brain injury (TBI) and aberrant microbiota also affect the aggregation of A beta. Here we provide an overview of the age-related early events and other pathological processes that precede A beta aggregation.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Time between milestone events in the Alzheimer's disease amyloid cascade
    Insel, Philip S.
    Donohue, Michael C.
    Berron, David
    Hansson, Oskar
    Mattsson-Carlgren, Niklas
    NEUROIMAGE, 2021, 227
  • [42] Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease
    Takahashi, Reisuke H.
    Nagao, Toshitaka
    Gouras, Gunnar K.
    PATHOLOGY INTERNATIONAL, 2017, 67 (04) : 185 - 193
  • [43] Alzheimer's Disease, Cerebrovascular Disease, and the β-amyloid Cascade
    Honjo, Kie
    Black, Sandra E.
    Verhoeff, Nicolaas P. L. G.
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2012, 39 (06) : 712 - 728
  • [44] Identification of β-aminopyrrolidine containing peptides as β-amyloid aggregation inhibitors for Alzheimer's disease
    Preetham, Habbanakuppe D.
    Muddegowda, Umashankara
    Kumar, Kothanahally S. Sharath
    Rangappa, Shobith
    Rangappa, Kanchugarakoppal S.
    JOURNAL OF PEPTIDE SCIENCE, 2022, 28 (06)
  • [45] Alzheimer's Disease: A Brief History of Immunotherapies Targeting Amyloid β
    Vogt, Anne-Cathrine S.
    Jennings, Gary T.
    Mohsen, Mona O.
    Vogel, Monique
    Bachmann, Martin F.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
  • [46] Experimental Traumatic Brain Injury Induces Rapid Aggregation and Oligomerization of Amyloid-Beta in an Alzheimer's Disease Mouse Model
    Washington, Patricia M.
    Morffy, Nicholas
    Parsadanian, Maia
    Zapple, David N.
    Burns, Mark P.
    JOURNAL OF NEUROTRAUMA, 2014, 31 (01) : 125 - 134
  • [47] Physiopathological modulators of amyloid aggregation and novel pharmacological approaches in Alzheimer's disease
    Defelice, FG
    Ferreira, ST
    ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS, 2002, 74 (02): : 265 - 284
  • [48] β-Amyloid oligomers in aging and Alzheimer's disease
    Zahs, Kathleen R.
    Ashe, Karen H.
    FRONTIERS IN AGING NEUROSCIENCE, 2013, 5
  • [49] Understanding the Amyloid Hypothesis in Alzheimer's Disease
    Paroni, Giulia
    Bisceglia, Paola
    Seripa, Davide
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 68 (02) : 493 - 510
  • [50] Alkannin Attenuates Amyloid ? Aggregation and Alzheimer?s Disease Pathology
    Hosoi, Toru
    Yazawa, Kyosuke
    Imada, Michihiro
    Tawara, Akari
    Tohda, Chihiro
    Nomura, Yasuyuki
    Ozawa, Koichiro
    MOLECULAR PHARMACOLOGY, 2023, 103 (05) : 266 - 273